You may have to Search all our reviewed books and magazines, click the sign up button below to create a free account.
This invaluable manual provides a practical overview of the field of gynecologic oncology. Focusing on clinical aspects of the specialty, it provides hands-on guidance for those caring for patients with ovarian, cervical, uterine, and lower genital tract cancers. It describes the current epidemiology, pathophysiology, presentation, diagnosis, and multimodality management of the most common gynecologic malignancies. Chapters are also devoted to radiation and chemotherapy, as well as symptom management. The book is designed for quick reference.
Prepared under the aegis of the Society of Gynecologic Oncologists, this handbook contains all the information clinicians need to care for patients undergoing chemotherapy for gynecologic cancers. Organized to provide quick access to critical information, the book outlines specific treatment regimens for gynecologic cancers by site and stage and offers detailed guidelines on choosing the best regimen for each patient, preparing patients for chemotherapy, and ameliorating side effects and complications. This edition includes all new drugs and chemotherapy regimens developed in the past seven years and provides expanded coverage of the use of blood products and hematologic growth factors.
This updated Fourth Edition provides comprehensive coverage of the biology of gynecologic cancer, the therapeutic modalities available, and the diagnosis and treatment of site-specific malignancies. Because of the importance of multimodality treatment, the site-specific chapters are co-authored by a surgical oncologist, a medical oncologist, a radiation oncologist, and a pathologist. A significant portion of this edition focuses on monoclonal antibodies, vaccines, and gene directed therapies and how they can greatly improve treatment outcomes. A new chapter on end-of-life care is also included. Three distinguished new editors—Richard R. Barakat, MD, Maurie Markman, MD, and Marcus E. Randall, MD—now join the editorial team.
Providing comprehensive coverage of the biology of gynecologic cancer, the therapeutic modalities available, and the diagnosis and treatment of site-specific malignancies, this edition has 30 percent new contributing authors and new material. A companion Web site offers a fully searchable text.
In recent years, there have been major advances in the treatment of patients with gynecologic malignancies. Perhaps the biggest advances have been in the area of ovarian cancer. Gynecologic Oncology focuses primarily upon this malignancy. This volume discusses cytoreductive surgery; screening for ovarian cancer; chemotherapy; new chemotherapeutic drugs; the controversy regarding the role of high-dose chemotherapy in gynecologic cancers; the hereditary basis for gynecologic malignancies; molecular genetics; molecular biology and new biologic therapies. Other topics covered are the treatment of all stages of cervical cancer, including radiotherapy. In addition, a chapter on advances in the pathology of gynecologic cancers is included. The advances made in the treatment of gynecologic malignancies are due, in part, to the clinical studies performed by many of the contributors to this volume. Clinical advances have been the result of multidisciplinary approaches which involve molecular biologists, pathologists, radiation therapists, surgeons and chemotherapists. Future advances will continue to rely upon collaborative interaction among these different disciplines.
The most readable, most comprehensive book in its field, Clinical Gynecologic Oncology, 9th Edition is the leading reference for diagnosis and treatment of gynecologic cancers – a must-have reference for improving outcomes and providing effective care. A "who’s who" list of contributing authors, under the editorial direction of Drs. Philip DiSaia and William Creasman, provides expert guidance on clinical presentations and management, now fully up to date with a brand-new design for faster, easier reference. Contains useful appendices covering staging, screening, nutritional therapy, toxicity criteria, blood component therapy, and radiation therapy. Covers hot topics such as multi-panel g...
Rev. ed. of: Clinical gynecologic oncology / Philip J. DiSaia, William T. Creaseman. 7th ed. 2007.
"All of the research has reinforced that ovarian cancer is not a silent disease as was once thought and as is shown quite eloquently in this collection of stories.... The value of this collection of stories is that it helps raise awareness about symptoms, need for patient persistence, and the importance of being treated by a gynecologic oncologist." Barbara A. Goff, MD Professor and Co-Director, Division of Gynecologic Oncology University of Washington School of Medicine Women of ages 17 to 78 join to tell their true stories. Find out about the lessons they have learned along their ovarian cancer journeys; from symptoms to diagnosis, trough treatments, and survival. Ovarian cancer facts: Occurs in 1 out of 57 women 89% have symptoms at the early stages of the disease 75% are diagnosed in the late stages of the disease 90% do not have history of ovarian cancer in their family Early detection is critical and can improve survival rate to 90%
Discusses the male and female reproductive systems, explaining how they work together to form new life, describing diseases that affect the system, and examining ethical debates from birth control to infertility.
A comprehensive surgical text, this book is designed to improve the reader's capability to implement important techniques essential to the effective management of ovarian cancer. With particular focus on the technical aspects of cytoreductive surgery, the book includes topics such as: pre-operative preparation, incisions/wound healing, surgical ins